Asymmetric Flow Field-Flow Fractionation |
Size |
High |
Relatively high |
Label-free |
Capacity limitation |
Manning et al. (2021)
|
Little damage to exosomes |
Required specialized equipment |
Subpopulations can be isolated |
Co-isolation with non-EVs particles |
Deterministic Lateral Displacement |
Size |
Low |
High |
Label-free |
Clogging membrane pores |
Smith et al. (2018); Hochstetter et al. (2020)
|
Time-saving |
Specific instrumentation |
Labor-saving |
Co-isolation with non-EVs particles |
Maintain the biological activity of exosomes |
Dielectrophoretic |
Size |
Relatively low |
Relatively low |
Label-free |
Low purity |
Tayebi et al. (2021); Zhang et al. (2022a)
|
High selectivity |
The device will overheat |
High controllability |
Tumor-derived exosomes are not separable |
Little damage to exosomes |
Acoustic Fractionation |
Size |
High |
Relatively high |
Simple |
Specialized instrumentation |
Wang et al. (2021)
|
Label-free |
Co-isolation with non-EVs particles |
Good biocompatibility |
Non-contact microfluidics |
Viscoelastic media flow |
Relatively high |
Relatively high |
Less contaminations |
Relatively low sensitivity |
Rodriguez-Quijada and Dahl, (2021)
|
Weak anti-interference ability |
EXODUS |
Size |
High |
Relatively high |
Fast |
Capacity limitation |
Chen et al. (2021)
|
Specific binding |
No clogging |
Required expertise and specialized equipment |
Repeatability |
Isolation and detection integration |
Exo-CMDS |
Charge |
High |
Relatively high |
Fast |
Membrane clogging |
Zhao et al. (2022)
|
Low cost |
Relatively expensive |
High purity |
Co-isolation with non-EVs particles |
High selectivity |
3D ZnO Nanoarrays |
Acoustic fluid |
Relatively low |
Relatively low |
Fast |
Specialized |
Hao et al. (2020)
|
High sensitivity |
Relatively expensive |
Multifunction |
Downstream analysis is possible |
Lipid microarrays |
Specific binding |
High |
Relatively low |
Fast |
Expensive |
Liu et al. (2021)
|
High sensitivity |
Low yield |
Small volume samples |
Difficult to apply to the clinic |
Inherent antifouling properties |
|
Capture by immunomagnetic beads |
Size |
High |
Relatively low |
High purity |
Capacity limitation |
Cheng et al. (2022); Zhang et al. (2022c); Zheng et al. (2022)
|
Specific binding |
Maintain the biological activity and morphological integrity of exosomes Easy to combine with specific analysis tools |
Chelator adverse effects |
Expensive |
Membrane clogging |
Co-isolation with non-EVs particles |
Synthetic polypeptide |
Specific binding |
Relatively high |
Relatively low |
Clinical application |
Expensive |
Bathini et al. (2021)
|
Vn96 captures exosomes |
High-throughput analysis |
Low yield |
Maintain the biological activity and morphological integrity of exosomes |
Relatively troublesome |
ExoSD |
Size |
Relatively high |
Relatively high |
Relatively high purity |
Specialized |
Yu et al. (2021)
|
Multifunction |
Capacity limitation |
Relatively high recovery rate |
|
Capturing exosomes with covalent chemistry |
Covalent chemistry |
Relatively high |
Relatively low |
Fast and automatic |
Relatively complex |
Dong et al. (2020); Han et al. (2020); Liu et al. (2022b); Sun et al. (2022)
|
High efficiency |
Relatively expensive |
Maintain the integrity of exosomes |
Relatively specialized |
Easy to combine with specific analysis tools |
Not suitable for larger volume samples |
|
Co-isolation with non-EVs particles |
|
Downstream analysis may be affected |